Active Implantable Medical Devices Market Size, Industry Forecast, Insights 2024-20323

"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Active Implantable Medical Devices Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $37.2 billion In 2028 At A CAGR Of 8.4% :

The active implantable medical devices market size has grown strongly in recent years. It will grow from $24.8 billion in 2023 to $26.89 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to strong economic growth in emerging markets, increased healthcare expenditure, increased prevalence of cardiovascular diseases, and growth in the number of healthcare facilities..

The active implantable medical devices market size is expected to see strong growth in the next few years. It will grow to $37.2 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. The growth in the forecast period can be attributed to the elderly population, government support, and increasing burden of neurological diseases. Major trends in the forecast period include launching new active implantable medical devices, partnerships and collaborations, integration of wireless technologies for implantable medical device charging, and integration of artificial intelligence (ai) to improve their product offerings and to stay competitive in the market..

Request A Sample Of This Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=8938&type=smp

Active Implantable Medical Devices Market Major Segments
The active implantable medical devices market covered in this report is segmented -

1) By Product Type: Cardiac Pacemakers, Implantable Cardioverter Defibrillators (ICD), Nerve Simulators, Cochlear Implants, Ventricular Assist Devices, Other Products
2) By Application: Cardiovascular, Neurological, Hearing Impairment, Other Applications
3) By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers

Key Driver - Cardiovascular Disease Surge Spurs Growth In Active Implantable Medical Devices Market

An increasing number of cardiovascular diseases is expected to propel the growth of the active implantable medical devices market going forward. Cardiovascular disease (CVD) refers to any condition that affects the heart or blood vessels. It is generally associated with the formation of fatty deposits inside the arteries (atherosclerosis) and an increased risk of blood clots. Active implantable medical devices are used to regulate or monitor irregular heartbeats in people who have specific heart rhythm problems or heart failure. The rise in the geriatric population has favored the demand for active implantable medical devices. For instance, in August 2022 according to a report published by the American College of Cardiology, a US-based non-profit medical association, cardiovascular risk factors are expected to increase from 2025 to 2060, with the highest proportional increase in diabetes (a 39.3% increase to 55 million), followed by dyslipidemia (a 27.6% increase to 126 million), hypertension (a 25.1% increase to 162 million), and obesity (18.3% to 126 million). The researchers have found that stroke (33.8% to 15 million) and heart failure (33.4% to 13 million) had the biggest expected increases in cardiovascular disease rates, followed by ischemic heart disease (30.7% to 29 million) and heart attack (16.9% to 16 million). Therefore, the increase in cardiovascular diseases is driving the growth of the active implantable medical devices market.

Customise This Report As Per Your Requirements -
https://www.thebusinessresearchcompany.com/Customise?id=8938&type=smp

Prominent Trend - Paving The Way For Growth In The Active Implantable Medical Devices Market

Product innovations have emerged as a key trend gaining popularity in the active implantable medical devices market. Major companies operating in the market are developing innovative products to sustain their position in the market. For instance, in June 2021, the researchers of Northwestern and George Washington University, a US-based nationally chartered private research university developed the first transitory pacemaker - a wireless, battery-free, totally implanted pacing device that vanishes when no longer required. The thin, flexible, and lightweight device can be utilized in patients who require temporary pacing following cardiac surgery or while awaiting a permanent pacemaker. All pacemaker components are biocompatible and will spontaneously dissolve into the body's biofluids over the course of five to seven weeks without the need for surgical extraction. Using near-field communication protocols, the device wirelessly gathers energy from an external, remote antenna. This eliminates the need for heavy batteries as well as stiff hardware such as wires (or leads).

Active Implantable Medical Devices Market Players
Major companies operating in the active implantable medical devices market report are Medtronic PLC, Boston Scientific Corporation, Cochlear Limited, Abbott Laboratories, Sonova Holding AG,MED-EL Medical Electronics, Livanova PLC, Biotronik Se & Co., Kg, MicroPort Scientific Corporation, Envoy Medical Corporation, Pregna International, Johari Digital Healthcare Limited, Renalyx Health Systems, Medprime Technologies, Comofi Medtech, Dynamed Equipments, Aurolab, Unicorn Denmart Limited, Lepu Medical Technology Company, Calon Cardio, Better Medical Technology, Beijing Aeonmed Co., Ltd, BONSS MEDICAL, Koninklijke Philips N.V., Berlin Heals Holding AG, CorWave SA, Philips Healthcare, Draegerwerk AG, Getinge Group, Ceryx Medical, MEDICO s.r.l., Medical-Łomża Sp. z o.o., Panop CZ, Medplant LLC, P.H.U. Medical, ProVeterináře, Johnson & Johnson, Baxter, Stryker, Axio Biosolutions, Cirtec Medical, Masimo, Teleflex Inc, NAGL MedTech, B Braun Argentina, Braile Biomedica Ltd, Megadyne Argentina, Embramed Industria e Comercio de Produtos Hospitalares Ltd, Arabian Medical Enterprises LLC, Zahrawi Group, Al Burak Medical Services, Lodox Systems, Glenmed Healthcare Solutions (PTY) Ltd, Lepeke Medical Group, LTE Medical Solutions

View The Full Report Here -
https://www.thebusinessresearchcompany.com/report/active-implantable-medical-devices-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the active implantable medical devices market in 2023. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the active implantable medical devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Active Implantable Medical Devices Market Report Structure
3. Active Implantable Medical Devices Market Trends And Strategies
4. Active Implantable Medical Devices Market - Macro Economic Scenario
5. Active Implantable Medical Devices Market Size And Growth
…..
27. Active Implantable Medical Devices Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.